ProfileOfResearchers

Identified 2

1

TITLE: Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
AUTHORS: Heiblig, Mael; Ferrada, Marcela A.; Koster, Matthew T.; Barba, Thomas; Gerfaud Valentin, Mathieu; Mekinian, Arsene; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Galland, Joris; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth J.; Kermani, Tanaz A.; Grayson, Peter C.; Patel, Bhavisha A.; Beck, David B.; Jamilloux, Yvan; Fenaux, Pierre; Sujobert, Pierre; ...More
PUBLISHED: 2022, SOURCE: BLOOD, VOLUME: 140, ISSUE: 8

INDEXED IN:

WOS

2

TITLE: Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study
AUTHORS: Heiblig, Mael; Ferrada, Marcela A.; Gerfaud Valentin, Mathieu; Barba, Thomas; Mekinian, Arsene; Koster, Matthew; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth; Kermani, Tanaz; Jamilloux, Yvan; Grayson, Peter C.; Patel, Bhavisha A.; Beck, David B.; Fenaux, Pierre; Sujobert, Pierre; ...More
PUBLISHED: 2021, SOURCE: BLOOD, VOLUME: 138

INDEXED IN:

WOS

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service